Prostate Cancer Metastasis to Stomach: A Case Report and Review of Literature.

gastrointestinal tract (GI tract) immunohistochemistry (IHC) prostate-specific antigen (PSA)

Journal

Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503

Informations de publication

Date de publication:
30 03 2023
Historique:
received: 01 03 2023
revised: 27 03 2023
accepted: 28 03 2023
medline: 17 5 2023
pubmed: 15 5 2023
entrez: 15 5 2023
Statut: epublish

Résumé

Metastatic prostate cancer is a common diagnosis with a protracted but terminal course. Gastrointestinal (GI) tract involvement is extremely rare, and reportedly portends a poor prognosis. It can present years after the initial prostate cancer diagnosis. Only fifteen cases of prostate cancer metastasis to the stomach have been reported in the literature. We report a case of a 72-year-old man with metastatic castration-resistant prostate cancer and extensive bony involvement. He presented a decade after the diagnosis of prostate cancer with signs of heartburn; a gastric biopsy was initially believed to represent primary gastric carcinoma, but subsequently a diagnosis of prostate cancer metastatic to the stomach was confirmed. This case highlights the importance of the provision of a pertinent clinical history and clinical differential diagnosis at the time of submission of surgical pathology specimens, as well as highlighting the need to have a low index of suspicion to pursue additional pathologic markers whenever a presumed second adenocarcinoma is noted in the context of a patient having a history of current or prior advanced-stage adenocarcinoma of another site. The correct diagnosis can shield the patient from the morbidity of inappropriate surgical or medical management.

Identifiants

pubmed: 37185408
pii: curroncol30040295
doi: 10.3390/curroncol30040295
pmc: PMC10137262
doi:

Types de publication

Case Reports Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

3901-3914

Références

J Gastric Cancer. 2014 Dec;14(4):271-4
pubmed: 25580360
J Clin Gastroenterol. 1992 Apr;14(3):251-4
pubmed: 1564301
Urol Int. 1999;63(3):193-7
pubmed: 10738193
Endoscopy. 2012;44 Suppl 2 UCTN:E47-8
pubmed: 22396273
J Cancer Res Ther. 2015 Jul-Sep;11(3):659
pubmed: 26458664
ACG Case Rep J. 2017 Mar 29;4:e47
pubmed: 28377935
J Urol. 1991 Sep;146(3):854-6
pubmed: 1714970
Surg Case Rep. 2020 Dec 2;6(1):303
pubmed: 33263827
Am J Gastroenterol. 1982 Jun;77(6):358-9
pubmed: 7091119
Urology. 2004 Apr;63(4):778-9
pubmed: 15072903
Case Rep Oncol Med. 2012;2012:292140
pubmed: 23243531
CMAJ. 2022 May 2;194(17):E601-E607
pubmed: 35500919
Eur Urol Focus. 2023 Jan;9(1):96-105
pubmed: 36058809
J Gastrointest Cancer. 2014 Dec;45 Suppl 1:40-3
pubmed: 23949554
Korean J Urol. 2010 Jun;51(6):431-3
pubmed: 20577612
Am J Surg Pathol. 2014 Aug;38(8):e6-e19
pubmed: 25029122
J Urol. 2021 Jan;205(1):22-29
pubmed: 32960678
Histol Histopathol. 2007 Jan;22(1):107-18
pubmed: 17128417
J Gastrointest Oncol. 2014 Dec;5(6):E113-6
pubmed: 25436133
Semin Diagn Pathol. 2005 Feb;22(1):88-104
pubmed: 16512601
Eur Urol. 2015 Aug;68(2):325-34
pubmed: 25108577
Pathologica. 2019 Sep;111(3):105-107
pubmed: 31748757
J Clin Gastroenterol. 2001 May-Jun;32(5):439-40
pubmed: 11319319
Cancer. 1990 Apr 1;65(7):1596-600
pubmed: 2311070
BMC Gastroenterol. 2017 Aug 7;17(1):93
pubmed: 28784100
J Investig Med. 1998 Feb;46(2):66-72
pubmed: 9549229
N Am J Med Sci. 2014 Mar;6(3):152-4
pubmed: 24741555
Future Oncol. 2015;11(4):691-702
pubmed: 25686122
Gastrointest Endosc. 2018 Oct;88(4):767-768
pubmed: 29758192
Health Rep. 2023 Jan 18;34(1):3-15
pubmed: 36716075
J Gastroenterol. 1997 Apr;32(2):236-40
pubmed: 9085174
Pan Afr Med J. 2017 Sep 29;28:95
pubmed: 29255565
Urol Case Rep. 2016 May 02;7:28-30
pubmed: 27335785
J Urol. 2021 Jan;205(1):14-21
pubmed: 32960679
Endoscopy. 2001 Jun;33(6):507-10
pubmed: 11437044
Clin Med Res. 2010 Mar;8(1):18-21
pubmed: 20305145

Auteurs

Leena Moshref (L)

Department of Surgery, University of Manitoba, Winnipeg, MB R3E 0V9, Canada.

Mohammad Abidullah (M)

Department of Pathology, University of Manitoba, Winnipeg, MB R3E 3P5, Canada.

Piotr Czaykowski (P)

Section of Hematology/Oncology, Department of Internal Medicine, University of Manitoba and CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada.

Amitava Chowdhury (A)

Department of Radiation Oncology, CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada.

Robert Wightman (R)

Department of Pathology, University of Manitoba, Winnipeg, MB R3E 3P5, Canada.

Pamela Hebbard (P)

Department of Surgery, University of Manitoba, Winnipeg, MB R3E 0V9, Canada.
Department of Surgical Oncology, CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH